A. Puel

Discipline

Psychologie (1)

Type de document

Articles (7)

Co-auteur

Date

Source

Mot-clé

Patients (5) Human beings (5) Patients (5) immunité (4) Interferon (4) Immunity (4) spectacle (3) infection (3) âge (3) adulte (3) jeune (3) Cases (3) Pneumonia (3) Infection (3) Errors (3) Autoantibodies (3) Older people (3) Age (3) Cases (3) Age (3) adulte (3) nourisson (2) enrichissement (2) maladie (2) enfant (2) Genes (2) Population (2) Influenza (2) Immunoglobulins (2) Population (2)

Documents écrit par A. Puel (7) | parle de A. Puel (0)

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
D. Matuozzo et al. (6 janv. 2024)
Correction to: New Dominant‑Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130‑Dependent Hyper‑IgE Syndrome.
T. Arlabosse et al.
New Dominant-Negative IL6ST Variants Expand the Immunological and Clinical Spectrum of GP130-Dependent Hyper-IgE Syndrome.
T. Arlabosse et al.
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.
A. Gervais et al. (4 sept. 2023)
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
D. Matuozzo et al. (5 avr. 2023)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
P. Bastard et al. (19 août 2021)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Q. Zhang et al. (23 oct. 2020)